| Hans-Günter Meyer-Thompson | Buprenorphin
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Tucciarone JM, Bandeira ID, Blasey C, Kratter IH, Ehrie J, Keller J, Pankow H, Chang M, Hawkins J, Evers AG, Bernert R, DeBattista C, Truong H, Rodriguez CI, Heifets BD, Schatzberg AF.
Am J Psychiatry. 2026 May 19:appiajp20250840. doi: 10.1176/appi.ajp.20250840. Epub ahead of print. PMID: 42151794.